Actress Selma Blair describes the many years it took for her multiple sclerosis to be diagnosed in this interview:
She needs prednisolone infusions for the flare up. If I were her, I would use the once every six months infusion of Ocrevus. In any case, she should consult with her doctors regarding either of these possibilities as each case has its own unique features. She could avoid reinventing the wheel by reading my book “Multiple Sclerosis Mission Remission: Healing MS Against All Odds” which is available on amazon and is described at http://www.msmissionremission.com
Gilenya was first pill for multiple sclerosis which was approved in 2010 for relapsing-remitting MS. In 2018 it was approved for use in children and adolescents. Another study found that it was a viable option for patients switching from Tysabri.
People often eventually switch from Tysabri to a different drug because they became JC positive. The JC virus is often latent in the brain, but if you become JC positive, new lesions could form on your brain.
In the study involving children and adolescents, Gilenya appeared to have the same or better results than people on Tysabri after two years. Gilenya is another option for people with multiple sclerosis. Its major advantage is that it has nothing to do with injection needles, because it’s a pill.
I have been on Ocrevus for seven months now, and so far, so good. Ocrevus is an infusion that you get once every six months. I will stick with Ocrevus because I have noticed that I respond better to infusions rather than pills. I believe this is because with pills, you are introducing another variable between yourself and the MS, which is your digestive system.
My digestive system must do something to medicines which is not a good thing. The infusion, I believe, leads to more direct treatment of the MS without having to go through my digestive system first.
Other people may experience different results because we are all different. Gilenya is another treatment option for MS patients which they can choose in consultation with their medical doctor.
Find a path to treatment of MS which can be individualized with consultation with your medical doctor. See https://www.amazon.com/gp/aw/d/B07D7JBZ5L/ref=cm_cr_othr_mb_bdcrb_top?ie=UTF8
Ocrevus was approved by the FDA in March of 2017. It is the only medication approved for primary progressive multiple sclerosis although it can also be used for relapsing-remitting MS. It has a different method of dealing with the immune system.
Most MS drugs modify the T-cells of the immune system. Ocrevus is one of the only drugs that targets the myelin-attacking mature B cells.
Ocrevus changes the B cells of the immune system which is, so far, more successful.
Ocrevus slowed the progression of primary progressive MS, which is the most severe form of multiple sclerosis. It also reduces disease activity. It is always good to have things quiet down with MS.
Primary progressive MS affects about ten percent of people with multiple sclerosis. It’s the type of multiple sclerosis that I have. How it was sent into remission is described in my book at https://www.amazon.com/Multiple-Sclerosis-Mission-Remission-Healing-ebook/dp/B07D7JBZ5L/ref=mp_s_a_1_2?ie=UTF8&qid=1529367853&sr=8-2&pi=AC_SX236_SY340_FMwebp_QL65&keywords=multiple+sclerosis+Mission+remission